SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001851734-21-000108
Filing Date
2021-11-16
Accepted
2021-11-16 17:02:23
Documents
84
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A fwbi20210930_10qa.htm   iXBRL 10-Q/A 1897868
2 EXHIBIT 31.1 ex_308344.htm EX-31.1 13004
3 EXHIBIT 31.2 ex_308345.htm EX-31.2 13030
4 EXHIBIT 32.1 ex_308346.htm EX-32.1 6056
  Complete submission text file 0001851734-21-000108.txt   10368109

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA azrx-20210930.xsd EX-101.SCH 104315
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azrx-20210930_cal.xml EX-101.CAL 50435
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azrx-20210930_def.xml EX-101.DEF 718956
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE azrx-20210930_lab.xml EX-101.LAB 599537
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azrx-20210930_pre.xml EX-101.PRE 753709
10 EXTRACTED XBRL INSTANCE DOCUMENT fwbi20210930_10qa_htm.xml XML 1550101
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37853 | Film No.: 211417117
SIC: 2834 Pharmaceutical Preparations